Zhen Xi May, Ross Glynis, Gauld Amanda, Nettel-Aguirre Alberto, Noonan Stephanie, Constantino Maria, Sweeting Arianne, Harding Anna-Jane, Mackie Adam, Chatila Hend, McGill Margaret, Middleton Timothy, Wu Ted, Twigg Stephen, Wong Jencia
Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Diabet Med. 2025 Aug;42(8):e70049. doi: 10.1111/dme.70049. Epub 2025 May 22.
AIMS: Young-onset type 2 diabetes mellitus (YT2DM) is an aggressive phenotype, with some claiming that diagnosis at <40 years of age represents a distinct higher risk group. Others have suggested restricting YT2DM to those diagnosed at <30 years of age. In this context, we examined whether pregnancy outcomes differ between women diagnosed with YT2DM at <30 years of age (T2D30) versus those diagnosed at 30 to <40 years of age (T2D40). METHODS: This retrospective analysis (2010-2019) compared pregnancy outcomes in women with pre-gestational T2D30 versus T2D40. Co-primary outcomes included preterm delivery, large for gestational age (LGA) infants, and pre-eclampsia. RESULTS: Compared to T2D40 (N = 69), T2D30 (N = 66) were significantly younger, had a longer duration of diabetes, and had higher rates of smoking (p <0.05 for all). In both groups, obesity affected ≥60% of women and similar rates of preterm delivery and LGA infants were seen. Women with T2D30 had at least a twofold increase in the adjusted odds of excess gestational weight gain (GWG). Rates of proteinuria and pre-eclampsia were increased in T2D30, although significance was lost following adjustment for factors such as glycaemia. Younger age of YT2DM diagnosis and longer duration of YT2DM (as continuous variables), but not maternal age, were independently associated with higher mean pregnancy HbA1c and excess GWG (p <0.05 for both). CONCLUSIONS: An earlier age of YT2DM diagnosis and/or longer duration of YT2DM were associated with excess GWG and a higher mean-pregnancy HbA1c. Rates of pre-eclampsia and proteinuria were increased in T2D30, likely mediated at least in part by factors such as glycaemia. Our findings suggest that the age of YT2DM diagnosis and/or duration of YT2DM, not just maternal age, should be considered when assessing pregnancy risks.
目的:青年发病型2型糖尿病(YT2DM)是一种侵袭性表型,一些人认为40岁之前确诊代表一个明显的高风险组。其他人则建议将YT2DM限定为30岁之前确诊的患者。在此背景下,我们研究了30岁之前确诊为YT2DM的女性(T2D30)与30至40岁之间确诊的女性(T2D40)的妊娠结局是否存在差异。 方法:这项回顾性分析(2010 - 2019年)比较了孕前T2D30和T2D40女性的妊娠结局。共同主要结局包括早产、大于胎龄(LGA)儿和子痫前期。 结果:与T2D40(N = 69)相比,T2D30(N = 66)年龄显著更小,糖尿病病程更长,吸烟率更高(所有p < 0.05)。在两组中,肥胖影响了≥60%的女性,早产和LGA儿的发生率相似。T2D30女性孕期体重过度增加(GWG)的校正比值至少增加两倍。T2D30的蛋白尿和子痫前期发生率增加,尽管在调整血糖等因素后显著性消失。YT2DM诊断时年龄更小以及YT2DM病程更长(作为连续变量),而非母亲年龄,与更高的平均妊娠糖化血红蛋白(HbA1c)和过度GWG独立相关(两者p < 0.05)。 结论:YT2DM诊断年龄更早和/或YT2DM病程更长与过度GWG和更高的平均妊娠HbA1c相关。T2D30的子痫前期和蛋白尿发生率增加,可能至少部分由血糖等因素介导。我们的研究结果表明,在评估妊娠风险时,应考虑YT2DM的诊断年龄和/或YT2DM病程,而不仅仅是母亲年龄。
Cochrane Database Syst Rev. 2016-6-7
Cochrane Database Syst Rev. 2017-6-11
Cochrane Database Syst Rev. 2018-1-5
Cochrane Database Syst Rev. 2017-11-5
Evid Rep Technol Assess (Full Rep). 2009-3
Cochrane Database Syst Rev. 2017-5-4
Cochrane Database Syst Rev. 2015-6-15
Lancet Diabetes Endocrinol. 2023-10
Diabetes Care. 2023-1-1
Obstet Gynecol. 2022-8-1
Diabetes Care. 2021-12-8
Lancet Diabetes Endocrinol. 2021-3
Aust N Z J Obstet Gynaecol. 2020-12